Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Processed Raspberry Council | UNKNOWN |
| Louisiana State University and A&M College | OTHER |
Not provided
Not provided
Not provided
Not provided
Red raspberries (Rubus idaeus) are a good source of health enhancing hydrolyzable and condensed tannins, flavonoids, anthocyanins, phenolic acids, rheosmin, potassium, carotenoids, vitamin C, and vitamin K1. Compared to other berries commonly consumed in the US, the health benefits of red raspberries to improve pre-diabetes mellitus (PDM) and type 2 diabetes have never been explored. The clinical study proposed in this project seeks to investigate the protective effect of whole red raspberries against insulin resistance, oxidative stress, and inflammation in PDM and type 2 diabetic patients. The in vitro study proposed in the project will assist in identifying the molecular mechanisms by which whole red raspberry protect islet cells against oxidative stress, insulin resistance and loss of cell function.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Raspberry Smoothies | Other | Single serving smoothies drink made with red raspberries to be consumed daily for two weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Raspberries | Other | Red raspberry smoothies drink |
|
| Measure | Description | Time Frame |
|---|---|---|
| Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) | Ratio of fasting insulin and glucose | 2 weeks |
| A high-sensitivity C-reactive protein (hs-CRP) measured in milligrams per liter | Measure of systemic inflammation | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| 3,4-Dihydroxyphenylacetic acid (DOPAC) measured in nanograms per milliliter | Measure of systemic inflammation | 2 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frank L Greenway, MD | Pennington Biomedical Research Center | Principal Investigator |
Not provided
Excel spreadsheets containing clinical trial data can be made available to other researchers after publication of research results.
Data will become available after publication of research results.
Academic researcher
Not provided
Not provided
| ID | Term |
|---|---|
| D007249 | Inflammation |
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |